304 related articles for article (PubMed ID: 36793715)
1. Sex-disaggregated outcomes of adverse events after COVID-19 vaccination: A Dutch cohort study and review of the literature.
Duijster JW; Lieber T; Pacelli S; Van Balveren L; Ruijs LS; Raethke M; Kant A; Van Hunsel F
Front Immunol; 2023; 14():1078736. PubMed ID: 36793715
[TBL] [Abstract][Full Text] [Related]
2. Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands.
Kant A; Jansen J; van Balveren L; van Hunsel F
Drug Saf; 2022 Apr; 45(4):319-331. PubMed ID: 35314943
[TBL] [Abstract][Full Text] [Related]
3. The Effect of Sex on the Incidence, Latency, Duration and Perceived Burden of Adverse Events Following Seasonal Influenza Vaccination in the Netherlands.
Slingerland P; van Hunsel FPAM; Lieber T; van Balveren L; Duijster JW
Drug Saf; 2023 Dec; 46(12):1323-1334. PubMed ID: 37882905
[TBL] [Abstract][Full Text] [Related]
4. The role of co-morbidities in the development of an AEFI after COVID-19 vaccination in a large prospective cohort with patient-reported outcomes in the Netherlands.
Ouaddouh C; Duijster JW; Lieber T; van Hunsel FPAM
Expert Opin Drug Saf; 2024 Mar; 23(3):323-331. PubMed ID: 37796980
[TBL] [Abstract][Full Text] [Related]
5. Spontaneously reported adverse events following COVID-19 basic and booster immunizations in the Netherlands.
van der Boor SC; Schmitz-de Vries ETJ; Smits D; Scholl JHG; Rolfes L; van Hunsel F
Vaccine; 2023 Jun; 41(29):4319-4326. PubMed ID: 37286408
[TBL] [Abstract][Full Text] [Related]
6. Willingness to receive a vaccine is influenced by adverse events following immunisation experienced by others.
Christou-Ergos M; Wiley KE; Leask J
Vaccine; 2023 Jan; 41(1):246-250. PubMed ID: 36446655
[TBL] [Abstract][Full Text] [Related]
7. Otorhinolaryngologic complications after COVID-19 vaccination, vaccine adverse event reporting system (VAERS).
Shin J; Shim SR; Lee J; Ryu HS; Kim JY
Front Public Health; 2023; 11():1338862. PubMed ID: 38269374
[TBL] [Abstract][Full Text] [Related]
8. Adverse Events Following Immunization Associated with Coronavirus Disease 2019 Vaccination Reported in the Mobile Vaccine Adverse Events Reporting System.
Jeon M; Kim J; Oh CE; Lee JY
J Korean Med Sci; 2021 May; 36(17):e114. PubMed ID: 33942578
[TBL] [Abstract][Full Text] [Related]
9. Active Safety Surveillance of Four Types of COVID-19 Vaccines: A National Study from Jordan.
Abdel-Qader DH; Abdel-Qader H; Silverthorne J; Kongkaew C; Al Meslamani AZ; Hayajneh W; Ata OMA; Shnaigat W; AbuRuz S; Al Nsour M; Alhariri A; Shnewer K; Da'ssan M; Obeidat NM; Nusair KE; Jalamdeh MS; Hawari F; Khader K; Hakim T; Hammad FA; Al Qudah M; Asad M
Clin Drug Investig; 2022 Oct; 42(10):813-827. PubMed ID: 35999428
[TBL] [Abstract][Full Text] [Related]
10. The short term safety of COVID-19 vaccines in Australia: AusVaxSafety active surveillance, February - August 2021.
Deng L; Glover C; Dymock M; Pillsbury A; Marsh JA; Quinn HE; Leeb A; Cashman P; Snelling TL; Wood N; Macartney K
Med J Aust; 2022 Aug; 217(4):195-202. PubMed ID: 35781813
[TBL] [Abstract][Full Text] [Related]
11. A 1-year analysis of adverse events following COVID-19 vaccination in Lebanon: a retrospective study.
Zeitoun A; Hallit S; Chehade S; Ibrahim A; Helali M; Allam C; Karam R
J Pharm Policy Pract; 2023 Feb; 16(1):24. PubMed ID: 36810279
[TBL] [Abstract][Full Text] [Related]
12. Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.
Rosenblum HG; Hadler SC; Moulia D; Shimabukuro TT; Su JR; Tepper NK; Ess KC; Woo EJ; Mba-Jonas A; Alimchandani M; Nair N; Klein NP; Hanson KE; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Mbaeyi SA; Oliver SE
MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(32):1094-1099. PubMed ID: 34383735
[TBL] [Abstract][Full Text] [Related]
13. Maternal, fetal and neonatal outcomes among pregnant women receiving COVID-19 vaccination: The preg-co-vax study.
Mascolo A; di Mauro G; Fraenza F; Gaio M; Zinzi A; Pentella C; Rossi F; Capuano A; Sportiello L
Front Immunol; 2022; 13():965171. PubMed ID: 36263025
[TBL] [Abstract][Full Text] [Related]
14. Cumulative Adverse Event Reporting of Anaphylaxis After mRNA COVID-19 Vaccine (Pfizer-BioNTech) Injections in Japan: The First-Month Report.
Iguchi T; Umeda H; Kojima M; Kanno Y; Tanaka Y; Kinoshita N; Sato D
Drug Saf; 2021 Nov; 44(11):1209-1214. PubMed ID: 34347278
[TBL] [Abstract][Full Text] [Related]
15. [Self-reported maternal adverse events of covid-19 vaccination during pregnancy].
Woestenberg PJ; Litjens CHC; Vissers LCM; Kant A; Berrens M; Vorstenbosch S
Ned Tijdschr Geneeskd; 2022 Dec; 166():. PubMed ID: 36633023
[TBL] [Abstract][Full Text] [Related]
16. Incidence and clinical characteristics of adverse neurological events and stroke-like syndrome associated with immune stress-related response after COVID-19 vaccination in 2021 from Thailand.
Sirisuk W; Limvorapitak W; Lolekha P; Methaset K; Kulkantrakorn K
Clin Neurol Neurosurg; 2023 Aug; 231():107804. PubMed ID: 37295197
[TBL] [Abstract][Full Text] [Related]
17. A Prospective Observational Study on BBV152 Coronavirus Vaccine Use in Adolescents and Comparison with Adults: Interim Results of the First Real-World Safety Analysis.
Kaur U; K L A; Chauhan M; Joshi A; Das A; Kansal S; Jaisawal V; Patwardhan K; Chakrabarti SS
Drug Saf; 2022 Oct; 45(10):1099-1109. PubMed ID: 36030299
[TBL] [Abstract][Full Text] [Related]
18. Adverse Events Following COVID-19 Vaccination in Selected Apartments in Bangalore, India.
Chakraborty A; Reval N; Kamath L
Cureus; 2022 Feb; 14(2):e21809. PubMed ID: 35291520
[TBL] [Abstract][Full Text] [Related]
19. [Adverse events following immunization reported with COVID-19 vaccines in Burkina Faso: Analysis of spontaneous reports].
Sawadogo R; Ouoba J; Ilboudo D; Tchoumbi E; Lankoandé-Haro S; Fofana S; Sombié I; Samadoulougou S; Kirakoya-Samadoulougou F
Sante Publique; 2024 Feb; 35(6):149-159. PubMed ID: 38388395
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 mRNA Vaccines Are Generally Safe in the Short Term: A Vaccine Vigilance Real-World Study Says.
Chen G; Li X; Sun M; Zhou Y; Yin M; Zhao B; Li X
Front Immunol; 2021; 12():669010. PubMed ID: 34093567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]